市場調查報告書

數位治療藥市場:全球市場分析與預測(各用途,各流通管道,各地區)

Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application ; Distribution Channel and Geography

出版商 The Insight Partners 商品編碼 755832
出版日期 內容資訊 英文 137 Pages
訂單完成後即時交付
價格
Back to Top
數位治療藥市場:全球市場分析與預測(各用途,各流通管道,各地區) Digital Therapeutics Market to 2025- Global Analysis and Forecasts by Application ; Distribution Channel and Geography
出版日期: 2018年12月03日內容資訊: 英文 137 Pages
簡介

本報告提供全球數位治療藥市場相關調查,彙整市場趨勢與各市場區隔概要,各地區趨勢,及市場與主要參與企業的簡介競爭趨勢相關資訊。

第1章 簡介

第2章 概要

第3章 市場情況

  • 概要
  • 市場區隔
  • PEST分析

第4章 主要市場趨勢

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 未來趨勢
  • 影響分析

第5章 全球市場分析

  • 市場收益預測與分析
  • 各地區市場
  • 值得注意的企業
  • 主要加入企業的實際成果
  • 專家的見解

第6章 各用途市場

  • 概要
  • 糖尿病市場
  • 心血管疾病市場
  • 中樞神經系統市場
  • 呼吸疾病市場
  • 戒煙市場
  • 肌肉骨骼疾病市場
  • 其他

第7章 各流通管道市場

  • 概要
  • 患者
  • 供應商
  • 付款者
  • 雇主

第8章 北美市場

第9章 歐洲市場

第10章 亞太地區市場

第11章 中東·非洲市場

第12章 中南美市場

第13章 企業簡介

  • PROPELLER HEALTH
  • CANARY HEALTH
  • NOOM, INC.
  • 2MORROW INC.
  • LIVONGO HEALTH
  • PROTEUS DIGITAL HEALTH
  • WELLDOC, INC
  • FITBIT, INC.
  • OMADA HEALTH, INC.
  • MANGO HEALTH

第14章 附錄

目錄
Product Code: TIPHC00002236

The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The digital therapeutics market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. The growth of the digital therapeutics market is primarily attributed to the rising pressure on healthcare providers to reduce healthcare costs, rising prevalence of chronic diseases and rising in the number of partnerships and collaborations in the market are the major factors that anticipated to propel the growth for the digital therapeutics market in the forecast period. However, increasing rate of cyber threat and rise in data security issues are expected to act as major challenges hindering the market growth. On the other hand, large number of undiagnosed population is expected to be prevalent future trend in the global digital therapeutics market

Global digital therapeutics market segmented into by application and distribution channel. Based on application, the market is segmented into diabetes, cardiovascular disease, central nervous system disease, respiratory diseases, smoking cessation, musculoskeletal disease, and others. On the basis of distribution channel, the digital therapeutics market classified as patients, providers, payers and employers.

The diabetes segment anticipated to the fastest and largest growing segment in the forecast period. The body's inability to produce or effectively utilize the hormone insulin, caused diabetes. This inability prevents the body from adequately regulating blood glucose levels. Digital therapeutics help to monitor the blood glucose level of patients, which helps in reducing the prevalence of diabetes across the globe. The increasing prevalence of diabetes help to enhance the demand for digital therapeutics that majorly helps in increasing the growth of this market.

The patients segment is expected to be the largest and fastest growing segment in the coming years. The increasing prevalence of diabetes helps to drive the market. Moreover, rise in the number of cases of dementia and Alzheimer's disease also help to upsurge the demand for digital therapeutics in the forecast period.

The digital therapeutics market was estimated through extensive primary and secondary sources that includes a vast array of government authorized websites such as Centers for Disease Control and Prevention (CDC), Habib Medical Group (HMG), Indian Council Of Medical Research (ICMR), International Diabetes Federation (IDF), World Health Organization (WHO) and others. The primary respondents included chair-holders and representatives of the demand and supply side for healthcare industries as well as medical professionals at digital therapeutics device manufacturing companies, hospitals, and research centers.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the digital therapeutics market.

Highlights key business priorities in order to assist companies to realign their business strategies

The key findings and recommendations highlight crucial progressive industry trends in the global digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

TABLES OF CONTENTS

1. INTRODUCTION 18

  • 1.1 SCOPE OF THE STUDY 18
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 18

2. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY TAKEAWAYS 19

3. GLOBAL DIGITAL THERAPEUTICS MARKET - MARKET LANDSCAPE 21

  • 3.1 OVERVIEW 21
  • 3.2 MARKET SEGMENTATION 21
    • 3.2.1 Global Digital Therapeutics Market- By Application 22
    • 3.2.2 Global Digital Therapeutics Market - By Distribution Channel 22
    • 3.2.3 Global Digital Therapeutics Market - By Geography 23
  • 3.3 PEST ANALYSIS 24
    • 3.3.1 North America - PEST Analysis 24
    • 3.3.2 Europe - PEST Analysis 26
    • 3.3.3 Asia Pacific - PEST Analysis 28
    • 3.3.4 Middle East and Africa (MEA) - PEST Analysis 30
    • 3.3.5 South and Central America - PEST Analysis 32

4. GLOBAL DIGITAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS 34

  • 4.1 KEY MARKET DRIVERS 34
    • 4.1.1 Rising Prevalence of Chronic Diseases 34
    • 4.1.2 Rising Pressure on Healthcare Providers to Reduce Healthcare Costs 35
    • 4.1.3 Rising in the Number of Partnerships and Collaborations in the Market 35
  • 4.2 KEY MARKET RESTRAINTS 36
    • 4.2.1 Cyber Threat and Rise in Data Security 36
  • 4.3 KEY MARKET OPPORTUNITY 36
    • 4.3.1 Large Number of Undiagnosed Population 36
  • 4.4 FUTURE TREND 38
    • 4.4.1 Increase in the Number of Start Ups 38
  • 4.5 IMPACT ANALYSIS 39

5. DIGITAL THERAPEUTICS MARKET- GLOBAL ANALYSIS 40

  • 5.1 GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN) 40
  • 5.2 GLOBAL DIGITAL THERAPEUTICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 41
  • 5.3 PROMINENT PLAYERS 42
  • 5.4 PERFORMANCE OF KEY PLAYERS 42
    • 5.4.1 Propeller Health 42
    • 5.4.2 CANARY HEALTH 42
  • 5.5 EXPERT OPINIONS 43

6. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY APPLICATION 44

  • 6.1 OVERVIEW 44
  • 6.2 DIABETES MARKET 45
    • 6.2.1 Overview 45
    • 6.2.2 Global Diabetes Market Revenue and Forecasts to 2025 (US$ Mn) 45
  • 6.3 CARDIOVASCULAR DISEASE MARKET 46
    • 6.3.1 Overview 46
    • 6.3.2 Global Cardiovascular Disease Market Revenue and Forecasts to 2025 (US$ Mn) 46
  • 6.4 CENTRAL NERVOUS SYSTEM DISEASE MARKET 47
    • 6.4.1 Overview 47
    • 6.4.2 Global Central Nervous System Disease Market Revenue and Forecasts to 2025 (US$ Mn) 47
  • 6.5 RESPIRATORY DISEASES MARKET 48
    • 6.5.1 Overview 48
    • 6.5.2 Global Respiratory Disease Market Revenue and Forecasts to 2025 (US$ Mn) 48
  • 6.6 SMOKING CESSATION MARKET 49
    • 6.6.1 Overview 49
    • 6.6.2 Global Smoking Cessation Market Revenue and Forecasts to 2025 (US$ Mn) 49
  • 6.7 MUSCULOSKELETAL DISEASE MARKET 50
    • 6.7.1 Overview 50
    • 6.7.2 Global Musculoskeletal Disease Market Revenue and Forecasts to 2025 (US$ Mn) 50
  • 6.8 OTHER APPLICATIONS MARKET 51
    • 6.8.1 Overview 51
    • 6.8.2 Global Other Applications Market Revenue and Forecasts to 2025 (US$ Mn) 51

7. GLOBAL DIGITAL THERAPEUTICS MARKET ANALYSIS - BY DISTRIBUTION CHANNEL 52

  • 7.1 OVERVIEW 52
  • 7.2 PATIENTS MARKET 53
    • 7.2.1 Overview 53
    • 7.2.2 Global Patients Market Revenue and Forecasts to 2025 (US$ Mn) 53
  • 7.3 PROVIDERS MARKET 54
    • 7.3.1 Overview 54
    • 7.3.2 Global Providers Market Revenue and Forecasts to 2025 (US$ Mn) 54
  • 7.4 PAYERS MARKET 55
    • 7.4.1 Overview 55
    • 7.4.2 Global Payers Market Revenue and Forecasts to 2025 (US$ Mn) 55
  • 7.5 EMPLOYERS MARKET 56
    • 7.5.1 Overview 56
    • 7.5.2 Global Employers Market Revenue and Forecasts to 2025 (US$ Mn) 56

8. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 57

  • 8.1 OVERVIEW 57
  • 8.2 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
  • 8.3 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY APPLICATION (US$ MN) 58
  • 8.4 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY DISTRIBUTION CHANNEL (US$ MN) 59
  • 8.5 NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59
  • 8.6 US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
    • 8.6.1 US Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 61
    • 8.6.2 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 61
    • 8.6.3 US Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 62
  • 8.7 CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
    • 8.7.1 Canada Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 64
    • 8.7.2 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 64
    • 8.7.3 Canada Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 65
  • 8.8 MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
    • 8.8.1 Mexico Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 67
    • 8.8.2 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 67
    • 8.8.3 Mexico Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 68

9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 69

  • 9.1 OVERVIEW 69
  • 9.2 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
  • 9.3 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70
  • 9.4 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71
  • 9.5 EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71
  • 9.6 GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
    • 9.6.1 Germany Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 73
    • 9.6.2 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 73
    • 9.6.3 Germany Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 74
  • 9.7 UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
    • 9.7.1 UK Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 76
    • 9.7.2 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 76
    • 9.7.3 UK Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 77
  • 9.8 FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
    • 9.8.1 France Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 78
    • 9.8.2 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 79
    • 9.8.3 France Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 79

10. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 80

  • 10.1 OVERVIEW 80
  • 10.2 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
  • 10.3 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
  • 10.4 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82
  • 10.5 ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82
  • 10.6 JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
    • 10.6.1 Japan Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 83
    • 10.6.2 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 84
    • 10.6.3 Japan Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 84
  • 10.7 CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
    • 10.7.1 China Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 86
    • 10.7.2 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 86
    • 10.7.3 China Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 87
  • 10.8 INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
    • 10.8.1 India Digital Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 89
    • 10.8.2 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 89
    • 10.8.3 India Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 90

11. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 91

  • 11.1 OVERVIEW 91
  • 11.2 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92
  • 11.3 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
  • 11.4 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93
  • 11.5 MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93
  • 11.6 UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94
    • 11.6.1 UAE Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 94
    • 11.6.2 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 95
    • 11.6.3 UAE Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 95
  • 11.7 SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 96
    • 11.7.1 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 96
    • 11.7.2 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 97
    • 11.7.3 Saudi Arabia Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 97
  • 11.8 SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 98
    • 11.8.1 South Africa Digital Therapeutics Revenue And Forecasts to 2025 (US$ Mn) 98
    • 11.8.2 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Application (US$ Mn) 99
    • 11.8.3 South Africa Digital Therapeutics Revenue And Forecasts to 2025, By Distribution Channel (US$ Mn) 99

12. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 100

  • 12.1 OVERVIEW 100
  • 12.2 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
  • 12.3 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101
  • 12.4 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102
  • 12.5 SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102
  • 12.6 BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 103
    • 12.6.1 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025 (US$ Mn) 104
    • 12.6.2 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Application (US$ Mn) 104
    • 12.6.3 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Distribution channel (US$ Mn) 105
    • 12.6.4 Brazil Digital Therapeutics Market Revenue And Forecasts to 2025, By Pharmaceutical Service (US$ Mn) 105

13. DIGITAL THERAPEUTICS MARKET-KEY COMPANY PROFILES 106

  • 13.1 PROPELLER HEALTH 106
    • 13.1.1 Key Facts 106
    • 13.1.2 Business Description 106
    • 13.1.3 Financial Overview 107
    • 13.1.4 Product/Services Portfolio 107
    • 13.1.5 SWOT Analysis 107
    • 13.1.6 Key Developments 107
  • 13.2 CANARY HEALTH 109
    • 13.2.1 Key Facts 109
    • 13.2.2 Business Description 109
    • 13.2.3 Financial Overview 109
    • 13.2.4 Product/Service Portfolio 109
    • 13.2.5 SWOT Analysis 110
    • 13.2.6 Key Developments 110
  • 13.3 NOOM, INC. 111
    • 13.3.1 Key Facts 111
    • 13.3.2 Business Description 111
    • 13.3.3 Financial Overview 111
    • 13.3.4 Product/Services Portfolio 111
    • 13.3.5 SWOT Analysis 112
    • 13.3.6 Key Developments 112
  • 13.4 2MORROW INC. 113
    • 13.4.1 Key Facts 113
    • 13.4.2 Business Description 113
    • 13.4.3 Financial Information 113
    • 13.4.4 Product/Services Portfolio 113
    • 13.4.5 SWOT Analysis 114
    • 13.4.6 Key Developments 114
  • 13.5 LIVONGO HEALTH 115
    • 13.5.1 Key Facts 115
    • 13.5.2 Business Description 115
    • 13.5.3 Financial Information 115
    • 13.5.4 Product/Service Portfolio 115
    • 13.5.5 SWOT Analysis 116
    • 13.5.6 Key Developments 116
  • 13.6 PROTEUS DIGITAL HEALTH 118
    • 13.6.1 Key Facts 118
    • 13.6.2 Business Description 118
    • 13.6.3 Financial Information 118
    • 13.6.4 Product/Service Portfolio 118
    • 13.6.5 SWOT Analysis 119
    • 13.6.6 Key Developments 119
  • 13.7 WELLDOC, INC 120
    • 13.7.1 Key Facts 120
    • 13.7.2 Business Description 120
    • 13.7.3 Financial Overview 120
    • 13.7.4 Product/Service Portfolio 120
    • 13.7.5 SWOT Analysis 121
    • 13.7.6 Key Developments 121
  • 13.8 FITBIT, INC. 123
    • 13.8.1 Key Facts 123
    • 13.8.2 Business Description 123
    • 13.8.3 Financial Overview 124
    • 13.8.4 Product/Service Portfolio 124
    • 13.8.5 SWOT Analysis 125
    • 13.8.6 Key Developments 125
  • 13.9 OMADA HEALTH, INC. 128
    • 13.9.1 Key Facts 128
    • 13.9.2 Business Description 128
    • 13.9.3 Financial Overview 128
    • 13.9.4 Product/Service Portfolio 128
    • 13.9.5 SWOT Analysis 129
    • 13.9.6 Key Developments 129
  • 13.10 MANGO HEALTH 130
    • 13.10.1 Key Facts 130
    • 13.10.2 Business Description 130
    • 13.10.3 Financial Overview 130
    • 13.10.4 Product/Service Portfolio 130
    • 13.10.5 SWOT Analysis 131
    • 13.10.6 Key Developments 131

14. APPENDIX 132

  • 14.1 ABOUT THE INSIGHT PARTNERS 132
  • 14.2 GLOSSARY OF TERMS 132
  • 14.3 METHODOLOGY 134
  • 14.4 COVERAGE 135
  • 14.5 SECONDARY RESEARCH 136
  • 14.6 PRIMARY RESEARCH 136

LIST OF TABLES

  • TABLE 1. PROPORTION OF PEOPLE LIVING WITH DIABETES (20-79 YEARS) WHO ARE UNDIAGNOSED PER REGION, 2017 37
  • TABLE 2. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 58
  • TABLE 3. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 61
  • TABLE 4. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 62
  • TABLE 5. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 64
  • TABLE 6. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 65
  • TABLE 7. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 67
  • TABLE 8. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 68
  • TABLE 9. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 70
  • TABLE 10. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 71
  • TABLE 11. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 73
  • TABLE 12. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 74
  • TABLE 13. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 76
  • TABLE 14. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 77
  • TABLE 15. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 79
  • TABLE 16. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 79
  • TABLE 17. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 81
  • TABLE 18. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 82
  • TABLE 19. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
  • TABLE 20. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 84
  • TABLE 21. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 86
  • TABLE 22. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 87
  • TABLE 23. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 89
  • TABLE 24. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 90
  • TABLE 25. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 92
  • TABLE 26. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 93
  • TABLE 27. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 95
  • TABLE 28. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 95
  • TABLE 29. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
  • TABLE 30. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 97
  • TABLE 31. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 99
  • TABLE 32. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 99
  • TABLE 33. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 101
  • TABLE 34. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 102
  • TABLE 35. BRAZIL DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 104
  • TABLE 36. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY DISTRIBUTION CHANNEL (US$ MN) 105
  • TABLE 37. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025, BY PHARMACEUTICAL SERVICE (US$ MN) 105
  • TABLE 38. GLOSSARY OF TERMS, DIGITAL THERAPEUTICS MARKET 132

LIST OF FIGURES

  • FIGURE 1. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 19
  • FIGURE 2. GLOBAL DIGITAL THERAPEUTICS MARKET BY APPLICATION, MARKET SHARE (%), 2017 20
  • FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, MARKET SHARE (%), 2017 20
  • FIGURE 4. DIGITAL THERAPEUTICS MARKET SEGMENTATION 21
  • FIGURE 5. DIGITAL THERAPEUTICS MARKET SEGMENTATION, BY REGION 22
  • FIGURE 6. NORTH AMERICA PEST ANALYSIS 24
  • FIGURE 7. EUROPE PEST ANALYSIS 26
  • FIGURE 8. ASIA PACIFIC PEST ANALYSIS 28
  • FIGURE 9. MIDDLE EAST AND AFRICA (MEA) PEST ANALYSIS 30
  • FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 32
  • FIGURE 11. DIGITAL THERAPEUTICS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 39
  • FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET- REVENUE FORECASTS AND ANALYSIS - 2017- 2025 (US$ MN) 40
  • FIGURE 13. GLOBAL DIGITAL THERAPEUTICS MARKET- BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 41
  • FIGURE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY APPLICATION, 2017 & 2025 (%) 44
  • FIGURE 15. GLOBAL DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
  • FIGURE 16. GLOBAL CARDIOVASCULAR DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
  • FIGURE 17. GLOBAL CENTRAL NERVOUS SYSTEM DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
  • FIGURE 18. GLOBAL RESPIRATORY DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
  • FIGURE 19. GLOBAL SMOKING CESSATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
  • FIGURE 20. GLOBAL MUSCULOSKELETAL DISEASE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
  • FIGURE 21. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
  • FIGURE 22. GLOBAL DIGITAL THERAPEUTICS MARKET SHARES BY DISTRIBUTION CHANNEL, 2017 & 2025 (%) 52
  • FIGURE 23. GLOBAL PATIENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
  • FIGURE 24. GLOBAL PROVIDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
  • FIGURE 25. GLOBAL PAYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 55
  • FIGURE 26. GLOBAL EMPLOYERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
  • FIGURE 27. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 57
  • FIGURE 28. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
  • FIGURE 29. NORTH AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017-2025) (%) 59
  • FIGURE 30. US DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
  • FIGURE 31. CANADA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
  • FIGURE 32. MEXICO DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
  • FIGURE 33. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (%) 69
  • FIGURE 34. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
  • FIGURE 35. EUROPE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 71
  • FIGURE 36. GERMANY DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
  • FIGURE 37. UK DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
  • FIGURE 38. FRANCE DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
  • FIGURE 39. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017), (US$ MN) 80
  • FIGURE 40. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
  • FIGURE 41. ASIA PACIFIC DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS, BY COUNTRY (2017 & 2025) (%) 82
  • FIGURE 42. JAPAN DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
  • FIGURE 43. CHINA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
  • FIGURE 44. INDIA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
  • FIGURE 45. MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 91
  • FIGURE 46. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 92
  • FIGURE 47. MIDDLE EAST AND AFRICA DIGITAL THERAPEUTICS REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 93
  • FIGURE 48. UAE DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 94
  • FIGURE 49. SAUDI ARABIA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 96
  • FIGURE 50. SOUTH AFRICA DIGITAL THERAPEUTICS REVENUE AND FORECASTS TO 2025 (US$ MN) 98
  • FIGURE 51. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US$ MN) 100
  • FIGURE 52. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 101
  • FIGURE 53. SOUTH AND CENTRAL AMERICA DIGITAL THERAPEUTICS MARKET REVENUE FORECAST, BY COUNTRY (2017 & 2025) (%) 102
  • FIGURE 54. BRAZIL DIGITAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 104
Back to Top